Two spine devicemakers are expecting full-year revenue increases, according to unaudited financial results posted Jan. 12.
Carlsmed, which develops aprevo personalized spine implants expects full-year revenue of $50.5 million, an 86% increase compared to 2024. Fourth quarter revenue is expected to reach $15.2 million.
Alphatec expects full-year revenue of $764 million, a 25% increase year over year. The company is also eyeing fourth quarter revenue of $212.2 million to $213.2 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
